Purchase Order AG52KJP130049

Tecan Genomics Inc. has been awarded a firm fixed-price purchase order valued at fifteen thousand seven hundred twenty-three dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA sequencing services. Specifically, the prime contractor will deliver universal plus total RNA sequencing with NuQuant human any deplete analysis for the NIH's infectious disease programs. Performance will take place in Redwood City, California over a four...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $14,460 firm-fixed price purchase order contract to Seqcenter LLC, a for-profit limited liability company, for the delivery of 25M RNA reads (rRNA depletion) and intermediate RNA analysis. The contract has an ultimate completion date of March 14, 2025, and was not set aside for any specific business category. Seqcenter, a small business, has previously secured several federal contracts with the USDA's...

The Department of Health and Human Services Food and Drug Administration awarded a $21,480 firm fixed price purchase order to Arraystar Inc. to provide transfer RNA sequencing services. The contract has a period of performance from August 1, 2023 through July 31, 2024 and will be performed in Potomac, Maryland. No additional context was provided regarding the FDA's programs or use of the contracted sequencing services. The award was made directly to Arraystar Inc. as the prime contractor, with...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...

The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...

This is a $109,080.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Novogene Corp Inc., a minority-owned small business. The contract is for long non-coding RNA and small RNA sequencing services to identify RNA biomarkers for radiation biodosimetry. The work includes sample preparation, sequencing, and data analysis for 216 mRNA/lncRNA samples and 96 small RNA samples. This effort builds on prior successful...

This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $13,943.66 firm fixed price delivery order is for reagents to support next-generation sequencing experiments in Dr. Calvo's laboratory. There is no set-aside designation for this contract. Illumina has previously received prime federal contracts and subcontracts from agencies such as the NIH, Centers...

This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...

Seqmatic, LLC has been awarded a $32,485 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide single nuclei RNA sequencing sample testing services. As a minority-owned and Asian-Pacific American owned small business, Seqmatic will leverage over 10 years of experience in next generation sequencing, single cell analysis, library preparation, and bioinformatics to deliver the...

This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...